Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2017 Nov;40(11):955-961.
doi: 10.1002/clc.22774. Epub 2017 Aug 14.

Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry

Affiliations
Multicenter Study

Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry

Avinainder Singh et al. Clin Cardiol. 2017 Nov.

Abstract

The YOUNG-MI registry is a retrospective study examining a cohort of young adults age ≤ 50 years with a first-time myocardial infarction. The study will use the robust electronic health records of 2 large academic medical centers, as well as detailed chart review of all patients, to generate high-quality longitudinal data regarding the clinical characteristics, management, and outcomes of patients who experience a myocardial infarction at a young age. Our findings will provide important insights regarding prevention, risk stratification, treatment, and outcomes of cardiovascular disease in this understudied population, as well as identify disparities which, if addressed, can lead to further improvement in patient outcomes.

Keywords: Atherosclerosis; Gender; Ischemic Heart Disease; Myocardial Infarction; Preventive Cardiology; Young Adults.

PubMed Disclaimer

Conflict of interest statement

Deepak L. Bhatt has served on advisory boards for Cardax, Elsevier PracticeUpdate Cardiology, Medscape Cardiology, and Regado Biosciences; has served on the board of directors for Boston VA Research Institute and Society of Cardiovascular Patient Care; has been chair of the American Heart Association Quality Oversight Committee; has served on data monitoring committees for Cleveland Clinic, Duke Clinical Research Institute, Harvard Clinical Research Institute, Mayo Clinic, Mount Sinai School of Medicine, and Population Health Research Institute; has received honoraria from American College of Cardiology (Senior Associate Editor, Clinical Trials and News, ACC.org), Belvoir Publications (editor in chief, Harvard Heart Letter), Duke Clinical Research Institute (clinical trial steering committees), Harvard Clinical Research Institute (clinical trial steering committee), HMP Communications (editor in chief, Journal of Invasive Cardiology), Journal of the American College of Cardiology (guest editor, associate editor), Population Health Research Institute (clinical trial steering committee), Slack Publications (chief medical editor, Cardiology Today's Intervention), Society of Cardiovascular Patient Care (secretary/treasurer), and WebMD (CME steering committees); has served as deputy editor for Clinical Cardiology, chair of the NCDR‐ACTION Registry Steering Committee, and chair of VA CART Research and Publications Committee; has received research funding from Amarin, Amgen, AstraZeneca, Bristol‐Myers Squibb, Chiesi, Eisai, Ethicon, Forest Laboratories, Ironwood, Ischemix, Lilly, Medtronic, Pfizer, Roche, Sanofi‐Aventis, and The Medicines Company; has received royalties from Elsevier (editor, Cardiovascular Intervention: A Companion to Braunwald's Heart Disease); has served as site co‐investigator for Biotronik, Boston Scientific, and St. Jude Medical (now Abbott); has served as trustee for the American College of Cardiology; and reports unfunded research from FlowCo, Merck, PLx Pharma, and Takeda. Ron Blankstein has served on the advisory board for Amgen, Inc., and has received research support from Amgen, Inc., and Gilead Sciences, Inc. Petr Jarolim has received research support through his institution from Abbott Laboratories, AstraZeneca, LP, Daiichi‐Sankyo, Inc., GlaxoSmithKline, Janssen Scientific Affairs, LLC, Merck & Co., Inc., Roche Diagnostics Corporation, Takeda Global Research and Development Center, and Waters Technologies Corporation. Ankur Gupta is supported by National Institutes of Health grant no. 5T32HL094301‐07. The authors declare no other potential conflicts of interest.

Figures

Figure 1
Figure 1
Schema of registry design. Abbreviations: CAD, coronary artery disease; CK‐MB, creatine kinase MB fraction; CV, cardiovascular; ICD, International Classification of Diseases; MI, myocardial infarction
Figure 2
Figure 2
Inclusion criteria, exclusion criteria, and case definition. Abbreviations: CAD, coronary artery disease; CNS, central nervous system; ECG, electrocardiogram; MI, myocardial infarction; PE, pulmonary embolism

References

    1. Eisen A, Giugliano RP, Braunwald E. Updates on acute coronary syndrome: a review. JAMA Cardiol. 2016;1:718–730. - PubMed
    1. Gupta A, Wang Y, Spertus JA, et al. Trends in acute myocardial infarction in young patients and differences by sex and race, 2001 to 2010. J Am Coll Cardiol. 2014;64:337–345. - PMC - PubMed
    1. Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667–1678. - PubMed
    1. Poon VT, Kuk JL, Ardern CI. Trajectories of metabolic syndrome development in young adults. PLoS One. 2014;9:e111647. - PMC - PubMed
    1. Otaki Y, Gransar H, Cheng VY, et al. Gender differences in the prevalence, severity, and composition of coronary artery disease in the young: a study of 1635 individuals undergoing coronary CT angiography from the prospective, multinational confirm registry. Eur Heart J Cardiovasc Imaging. 2015;16:490–499. - PMC - PubMed

Publication types

LinkOut - more resources